Detalhe da pesquisa
1.
Improving Right Ventricular Function by Increasing BMP Signaling with FK506.
Am J Respir Cell Mol Biol
; 65(3): 272-287, 2021 09.
Artigo
Inglês
| MEDLINE | ID: mdl-33938785
2.
FHIT, a Novel Modifier Gene in Pulmonary Arterial Hypertension.
Am J Respir Crit Care Med
; 199(1): 83-98, 2019 01 01.
Artigo
Inglês
| MEDLINE | ID: mdl-30107138
3.
Antiproliferative effect of selexipag active metabolite MRE-269 on pulmonary arterial smooth muscle cells from patients with chronic thromboembolic pulmonary hypertension.
Pulm Circ
; 13(2): e12231, 2023 Apr.
Artigo
Inglês
| MEDLINE | ID: mdl-37180827
4.
The selective PGI2 receptor agonist selexipag ameliorates Sugen 5416/hypoxia-induced pulmonary arterial hypertension in rats.
PLoS One
; 15(10): e0240692, 2020.
Artigo
Inglês
| MEDLINE | ID: mdl-33057388
5.
Delineating the molecular and histological events that govern right ventricular recovery using a novel mouse model of pulmonary artery de-banding.
Cardiovasc Res
; 116(10): 1700-1709, 2020 08 01.
Artigo
Inglês
| MEDLINE | ID: mdl-31738411
6.
Regulation of dendrite growth by the Cdc42 activator Zizimin1/Dock9 in hippocampal neurons.
J Neurosci Res
; 87(8): 1794-805, 2009 Jun.
Artigo
Inglês
| MEDLINE | ID: mdl-19156867
7.
A comparison of vasodilation mode among selexipag (NS-304; [2-{4-[(5,6-diphenylpyrazin-2-yl)(isopropyl)amino]butoxy}-N-(methylsulfonyl)acetamide]), its active metabolite MRE-269 and various prostacyclin receptor agonists in rat, porcine and human pulmonary arteries.
Eur J Pharmacol
; 795: 75-83, 2017 Jan 15.
Artigo
Inglês
| MEDLINE | ID: mdl-27919660
8.
NS-018 reduces myeloma cell proliferation and suppresses osteolysis through inhibition of the JAK2 and Src signaling pathways.
Blood Cancer J
; 8(7): 62, 2018 06 25.
Artigo
Inglês
| MEDLINE | ID: mdl-29941953
9.
Antiproliferative and antitumor effects of azacitidine against the human myelodysplastic syndrome cell line SKM-1.
Anticancer Res
; 32(3): 795-8, 2012 Mar.
Artigo
Inglês
| MEDLINE | ID: mdl-22399596